Just Published: "Kazakhstan Pharmaceuticals & Healthcare Report Q1 2016"

Kazakhstan's pharmaceutical market will co ntinue to grow at a rapid pace over our forecast period. Its accession into the Eurasian Economic Union (EAEU) will lead to access to better quality drugs at lower prices, increasing consumption as the country forms and integrates a common market for pharmaceuticals. Government expenditure on health continues to play a key role in boosting medicine consumption. However, unless the government steps up economic diversification and decreases its reliance on the oil sector, we doubt it will be able to sustain its current level of spending over the long-term.

Headline Expenditure Projections

Pharmaceuticals: KZT310.05bn (USD1.73bn) in 2014 to KZT349.57bn (USD1.61bn) in 2015; +12.7% in local currency terms and -6.6% in US dollar terms. Forecast in line with last quarter.
Healthcare: KZT1.76trn (USD9.78bn) in 2014 to KZT2.05trn (USD9.45bn) in 2015; +16.6% in local currency terms and -3.4% in US dollar terms. Forecast in line with last quarter.

Full Report Details at
- http://www.fastmr.com/prod/1109898_kazakhstan_pharmaceuticals.aspx?afid=301

The Kazakhstan Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Kazakhstan Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Kazakhstan pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Kazakhstan, to test other views - a key input for successful budgeting and strategic business planning in the Kazakhstani pharmaceutical and healthcare market.
* Target business opportunities and risks in the Kazakhstani pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Kazakhstan.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- France Pharmaceuticals & Healthcare Report Q1 2016
- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2016
- Ukraine Pharmaceuticals & Healthcare Report Q1 2016
- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016